IL4 and psoriasis: A prospective dose-escalation study of human IL-4, which included 20 patients with severe psoriasis, revealed that IL-4 treatment markedly improved psoriasis and induced a pronounced skewing toward Th2 cytokine production in both psoriatic skin lesions and the circulation [61].